Hot topics in medicines advertising 2022

Thursday 17 March 2022

About

This webinar will explore current topics in the regulation of medicines advertising and is targeted at but not limited to; pharmaceutical companies and their agents involved in advertising development and sign-off. Those involved in advertising and marketing of medicines, medical affairs and regulatory affairs.

At this webinar participants will learn:

  • How to make sure advertising is compliant
  • Vetting procedures
  • Common problems identified from casework
  • The latest regulatory updates, particularly changes following the departure of the UK from the EU


CPD credits: 2 credits available for full attendance.

 

Questions For The Panel

Once you have registered, you will have the opportunity to submit pre-event questions to our panel of speakers via the Delegate Area. You will be issued with login details on your registration confirmation email. The team will endeavour to answer as many of these questions as they can at the event.

To submit your questions, please log into the Delegate Area and go to Panel Questions in the menu.

Delegates will also have the opportunity to also submit their questions at the live event.

Twitter - #HotTopicsinAdvertising22

Agenda

Please note agenda timings are subject to change.

Hot Topics Agenda — full schedule

March 17th, 10:30 - 12:30

Welcome and Introduction

Beryl Keeley — AIMS Group Manager, MHRA

Review of the year: What's new?

Beryl Keeley — AIMS Group Manager, MHRA

Getting it right: Top tips from vetting

Claire Tilstone — Advertising Standards & Outreach Unit Manager, MHRA

Learnings from 2020 vetting casework for prescription and OTC medicines

Self-Regulation 1: PMCPA

Heather Simmonds — Director, PMCPA

Report on PMCPA casework and the ABPI Code

Self-regulation 2: PAGB

Laura Kelly — Advertising Services Manager, PAGB

Review of PAGB initiatives, with a focus on digital content

Panel session

Panel: MHRA, PMCPA, PAGB

Webinar close

Speakers

Register

Please check back for registration information.

Contact Us